Biorce has raised $52.5 million in Series A funding to enhance its AI-driven clinical trial technology. This investment marks a significant step in revolutionizing how clinical trials are conducted, promising faster and more efficient processes.

Source: https://news.google.com/rss/articles/CBMilAFBVV95cUxONGlIaVhpcVNFZlJWbS1MU2ZISFVOcVk4eDdBelh2WDFaNU45X250WnYwSllRdG12bm5PWjFOdDF1SnVWUlg0QVdsbjlBOXRWY2R4Y0puNWl6TEpmZ1RVYjBreFFZSU04MkZ3NlE3VDdvU1FwOWgtTDhGMXRrU19JOFpnUnhrcnVIRVZjcFlDSGpFOHdJ?oc=5
